Skip to content

Short-term Outcome in STEMI Patients Undergoing Primary PCI: A Comparative Study Between Rural and Urban Communities at Assiut University.

Short-term Outcome of Patients From Rural Versus Urban Communities Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07136831
Enrollment
162
Registered
2025-08-22
Start date
2025-08-15
Completion date
2026-12-30
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MACE, In STEMI

Brief summary

this study aims to assess the short-term (3-month) clinical and echocardiographic outcomes of primary PCI among STEMI patients from rural versus urban areas in Upper Egypt. A special focus will be placed on identifying predictors of MACE. The findings may offer valuable insight into optimizing STEMI care pathways and support the development of regional STEMI networks across Egypt.

Detailed description

ST-segment elevation myocardial infarction (STEMI) is a life-threatening condition that requires urgent reperfusion therapy, with primary percutaneous coronary intervention (PCI) being the gold standard of care. While PCI significantly reduces complications and improves survival, access to this intervention remains unequal, particularly between rural and urban populations According to the latest census definitions, a rural area is characterized by:A population of fewer than 5,000,A population density of less than 400 persons per square kilometer,And more than 25% of the male working population engaged in agriculture. Rural patients often experience delayed diagnosis, limited access to PCI-capable centers, and prolonged ischemic times. These factors contribute to poorer clinical outcomes, including higher rates of reinfarction, heart failure, and mortality. In contrast, urban residents typically have faster access to specialized cardiac care and more efficient treatment pathways. In Upper Egypt, this urban-rural gap is particularly pronounced, with rural patients facing substantial logistical and systemic challenges in receiving timely PCI. Although efforts have been made to expand PCI access nationwide, there remains a lack of localized data comparing short-term outcomes-particularly major adverse cardiovascular events (MACE)-between rural and urban STEMI patients.

Interventions

A catheter-based invasive procedure used to open blocked coronary arteries in patients presenting with ST-elevation myocardial infarction (STEMI).

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Adults aged ≥18 years. 2. Confirmed diagnosis of ST-segment elevation myocardial infarction (STEMI) based on ECG and cardiac biomarkers. 3\. Underwent primary percutaneous coronary intervention (PCI) within the study period. 4\. Known and verified residential address classified as rural or urban based on official definitions (e.g., UK or WHO classification). 5\. Informed consent obtained

Exclusion criteria

1. Non-STEMI or unstable angina cases. 2. Patients who received fibrinolytic therapy instead of PCI. 3. Transfer from another facility after more than 12 hours of symptom onset. 4. Patients with previous revascularization (e.g., CABG or PCI within the last 6 months). 5. Incomplete clinical data or unknown residential location. \-

Design outcomes

Primary

MeasureTime frameDescription
Incidence of major adverse cardiovascular events (MACE) among STEMI patients undergoing primary percutaneous coronary intervention (PCI),3 monthUnite of measurement : Number of patients experiencing MACE (% of total)

Contacts

Primary ContactFatma ali khallaf Dr fatma ali
blsmakn6@gmail.com+201000465132
Backup ContactHatem Abdelrahman, Professor
dr.hatemabdelrahman@aun.edu.eg+20 10 05212162

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026